SCHEMBL2443905

SCHEMBL2443905

C=CN(C(=O)CC)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445338 0.83 ALDH1A1 (0.34) TSHRALDH1A1
SCHEMBL2441461 0.79 ALDH1A1 (0.47) TSHRALDH1A1
SCHEMBL2445429 0.78 EPHX2 (0.43) TSHRALDH1A1
SCHEMBL2941814 0.77 EPHX2 (0.46) TSHRALDH1A1
SCHEMBL2442876 0.77 EPHX2 (0.46) TSHRALDH1A1
SCHEMBL2945838 0.77 EPHX2 (0.46) TSHRALDH1A1
SCHEMBL2445477 0.77 EPHX2 (0.46) TSHRALDH1A1
SCHEMBL2443791 0.77 EPHX2 (0.46) TSHRALDH1A1
SCHEMBL25822445 0.76
SCHEMBL2441885 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10551345-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2020-02-04 US claimed
US-20170356877-A1 POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2017-12-14 US claimed
US-9671367-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2017-06-06 US claimed
US-20140209461-A1 Poly and Copoly(N-vinylamide)s and Their Use In Capillary Electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2014-07-31 US claimed
EP-2053067-B1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS LLC (US) 2011-09-14 EP claimed
CN-101724216-A Poly and copolyn(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS 2010-06-09 CN claimed
US-20100051461-A1 Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis Life Technologies Corporation (US) 2010-03-04 US claimed
US-7641765-B2 Applying slurry containing optical brighteners BASF AKTIENGESELLSCHAFT (DE) 2010-01-05 US claimed
CN-100567339-C (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2009-12-09 CN claimed
EP-2053067-A1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis Applied Biosystems Inc. (US) 2009-04-29 EP claimed
EP-1636279-B1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS (US) 2009-02-18 EP claimed
CN-1816573-A (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis APPLERA CORP (US) 2006-08-09 CN claimed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 US claimed
CN-120025625-A Foaming composition and application thereof, foaming material and preparation method and application thereof 中国石油化工股份有限公司 2025-05-23 CN disclosed
CN-117986814-A Antibacterial biodegradable expanded beads, preparation method thereof, expanded bead molded body and application thereof 中国石油化工股份有限公司 2024-05-07 CN disclosed
CN-117946489-A Composite antibacterial agent, blown film, preparation method and application thereof, antibacterial biodegradable polyester composition, polyester material and preparation method 中国石油化工股份有限公司 2024-04-30 CN disclosed
US-20030130454-A1 Process for producing amphipathic polymers MITSUBISHI RAYON CO., LTD. 2003-07-10 US disclosed
WO-2003020808-A1 REINFORCEMENT OF THE EFFECT OF OPTICAL BRIGHTENERS BY MEANS OF POLYMERS BASF AKTIENGESELLSCHAFT (DE) 2003-03-13 WO disclosed
WO-2003021041-A2 METHOD FOR INCREASING THE WHITENESS OF PAPER BY MEANS OF CATIONIC POLYELECTROLYTES BASF AKTIENGESELLSCHAFT (DE) 2003-03-13 WO disclosed
WO-2003016624-A1 METHOD FOR PRODUCTION OF COATED PAPER WITH EXTREME WHITENESS BASF AKTIENGESELLSCHAFT (DE) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides POLI, PCNA, POLL TSHR 4259/4885ALDH1A1 3357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.